SCHEMBL7052037

SCHEMBL7052037

O=C(O)c1cccc(OCc2ccc(Cl)cc2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 10/20 1.00
MAOA P21397 1/20 0.76
MAOB P27338 1/20 0.76
MRGPRX4 Q96LA9 3/20 0.74
RXRA P19793 1/20 0.74
RXRB P28702 1/20 0.74
RXRG P48443 1/20 0.74
NR4A1 P22736 2/20 0.68
NR4A3 Q92570 2/20 0.68
SMPD1 P17405 1/20 0.67
PPARA Q07869 1/20 0.67
NPC1 O15118 2/20 0.65
RAB9A P51151 2/20 0.65
MEN1 O00255 1/20 0.65
POLB P06746 1/20 0.65
KMT2A Q03164 1/20 0.65
SENP8 Q96LD8 1/20 0.65
SENP7 Q9BQF6 1/20 0.65
SENP6 Q9GZR1 1/20 0.65
SRD5A2 P31213 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30994900 0.88 NR4A2 (0.82) NR4A2MAOBMRGPRX4RXRARXRB
SCHEMBL27815839 0.88 NR4A2 (0.82) NR4A2MAOBMRGPRX4RXRARXRB
SCHEMBL30207018 0.87 NR4A2 (1.00) NR4A2MAOBMRGPRX4NR4A1NR4A3
SCHEMBL339009 0.87 NR4A2 (1.00) NR4A2MAOBMRGPRX4NR4A1NR4A3
SCHEMBL1436284 0.87 MAOB (1.00) NR4A2MAOAMAOBRXRARXRB
SCHEMBL13802461 0.87 NR4A2 (1.00) NR4A2MAOAMAOBMRGPRX4RXRA
SCHEMBL4638741 0.87 NR4A2 (0.76) NR4A2MAOAMAOBMRGPRX4RXRA
SCHEMBL29784229 0.87 NR4A2 (1.00) NR4A2MAOAMAOBMRGPRX4RXRA
SCHEMBL1123155 0.86 NR4A2 (0.91) NR4A2MAOBMRGPRX4NR4A1NR4A3
Hydrochloric Acid SCHEMBL4748074 0.86 NR4A2 (0.97) NR4A2MAOBMRGPRX4NR4A1NR4A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030191323-A1 Hypoglycemic agent AJINOMOTO CO., INC. (JP) 2003-10-09 US disclosed
US-20030162818-A1 Acylsulfonamide derivative AJINOMOTO CO. INC. (JP) 2003-08-28 US disclosed
US-6555584-B1 Acetyl-coa carboxylase inhibitors AJINOMOTO CO., INC. (JP) 2003-04-29 US disclosed
EP-1300142-A1 HYPOGLYCEMICS Ajinomoto Co., Inc. (JP) 2003-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162818-A1 Acylsulfonamide derivative ACSS2, ACACA, FASN NR4A2 2332/4885MAOA 591/4885MAOB 396/4885
US-20030191323-A1 Hypoglycemic agent GPR119, IAPP, SLC5A2 NR4A2 3157/4885MAOA 2901/4885MAOB 2736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.